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 Abstract 
There is an ever-increasing need to develop dental implants with ideal characteristics to 
achieve specific and desired biological response in the scope of improve the healing 
process post-implantation. Following that premise, enhancing and optimizing titanium 
implants through superficial treatments, like silica sol-gel hybrid coatings, are regarded 
as a route of future research in this area. These coatings change the physicochemical 
properties of the implant, ultimately affecting its biological characteristics. Sandblasted 
acid-etched titanium (SAE-Ti) and a silica hybrid sol-gel coating (35M35G30T) applied 
onto the Ti substrate were examined. The results of in vitro and in vivo tests and the 
analysis of the protein layer adsorbed to each surface were compared and discussed.  
In vitro analysis with MC3T3-E1 osteoblastic cells, showed that the sol-gel coating raised 
the osteogenic activity potential of the implants (the expression of osteogenic markers, 
the alkaline phosphatase (ALP) and IL-6 mRNAs, increased). In the in vivo experiments 
using as model rabbit tibiae, both types of surfaces promoted osseointegration. However, 
the coated implants demonstrated a clear increase in the inflammatory activity in 
comparison with SAE-Ti. Mass spectrometry (LC-MS/MS) analysis showed differences 
in the composition of protein layers formed on the two tested surfaces. Large quantities 
of apolipoproteins were found attached predominantly to SAE-Ti. The 35M35G30T 
coating adsorbed a significant quantity of complement proteins, which might be related 
to the material intrinsic bioactivity, following an associated, natural and controlled 
immune response.  
The correlation between the proteomic data and the in vitro and in vivo outcomes is 
discussed on this experimental work. 
Keywords: 
Dental implants, apolipoproteins, osteoimmunology, osteogenesis, bone regeneration, 
proteomics  
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1. Introduction 
Titanium is a material often used in dental implants due to its high biocompatibility, 
resistance to corrosion and good mechanical properties, such as its strength and 
relatively low modulus of elasticity [1]. These are excellent characteristics for biomedical 
purposes. However, specific surface treatments might enhance the bioactivity of titanium 
devices, leading to the desired biological response [2]. Such surface modifications are 
designed to boost osseointegration in dental implants, improving tissue healing [3]. 
The degree of integration of a biomaterial in a living organism depends on the interaction 
of many factors in the microenvironment formed after the implantation. The first layer of 
proteins adsorbed onto the biomaterial surface might have a strong effect on the 
development and activation of several biological processes. The success of implantation 
might depend on these proteins, spreading and adsorbing on the surface by competitive 
displacement (Vroman effect) [4]. 
Coagulation cascades, complement system pathways, platelets and immune cells are 
activated and become involved immediately in the microenvironment formed after the 
surgical procedure, starting the process of inflammation [5]. The deposition of the 
proteins activating these processes depends on distinct features of the surfaces. The 
preferential adsorption of certain types of proteins might be associated with the specific 
physical and chemical properties of these materials [6]. Hence, controlling the amount, 
type and the conformation of the adhering proteins is of the utmost importance in 
promoting the correct, fast tissue regeneration. It is vital to obtain a moderate and natural 
immune response (not a chronic inflammation) to the biomaterial. Such a response 
should favour the regeneration and good osseointegration, thus contributing to the 
success of the implantation [7]. 
The use of silica sol-gel hybrid materials in biomedical applications is becoming 
increasingly widespread [8–10]. The versatility of the sol-gel techniques allows tuning 
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the final physicochemical properties of a biomaterial by selection of appropriate 
precursors and optimisation of synthesis parameters [11]. The hybrid silica sol-gel 
materials can be applied easily as a coating onto titanium, bioactivating the surface and 
conferring the desired properties to the implants. These coatings are biocompatible and 
biodegradable, with osteoinductive properties due to the release of silicon compounds 
during their hydrolytic degradation [8–10]. Silicon is an essential element in bone 
metabolism and it is involved in the formation and mineralisation of this tissue [12]. 
The behaviour of sandblasted, acid-etched titanium (SAE-Ti) and a hybrid silica sol-gel 
coating applied onto this substrate was compared using in vitro and in vivo tests. The 
pattern of proteins adsorbed onto these two surface types was analysed. Then, the 
results of the proteomic study of protein–biomaterial interactions were compared with the 
outcomes of in vitro and in vivo studies. 
  
5 
 
2. Materials and methods 
2.1. Titanium discs 
Ti discs (12 mm in diameter, 1-mm thick) were made from a bar of commercially 
available, pure, grade-4 Ti (Ilerimplant-GMI S.L., Lleida, Spain). To obtain the 
sandblasted, acid-etched (SAE) Ti, the discs were abraded with 4-μm aluminium oxide 
particles and acid-etched by submersion in sulfuric acid for 1 h, to simulate a moderately 
rough implant surface. Discs were then washed with acetone, ethanol and 18.2-Ω 
puriﬁed water (for 20 min in each liquid) in an ultrasonic bath and dried under vacuum. 
Finally, all Ti discs were sterilised using UV radiation. 
2.2. Sol-gel synthesis and sample preparation 
The silica hybrid material was obtained through the sol-gel route. The precursors used 
were the alkoxysilanes: methyltrimethoxysilane, 3-(glycidoxypropyl)-trimethoxysilane 
and tetraethyl orthosilicate (Sigma-Aldrich, St. Louis, MO, USA) in molar percentages of 
35%, 35% and 30%, respectively. This composition, 35M35G30T, was chosen based on 
previous studies [8]. 2-Propanol (Sigma-Aldrich, St. Louis, MO, USA) was used as a 
solvent in the synthesis at a volume ratio (alcohol:siloxane) of 1:1. Hydrolysis of 
alkoxysilanes was carried out by adding (at a rate of 1 drop s-1) the corresponding 
stoichiometric amount of acidified aqueous solution of 0.1M HNO3 (Panreac, Barcelona, 
Spain). The mixture was kept for 1 h under stirring and then 1 h at rest. The samples 
were prepared immediately afterwards. SAE-titanium was used as the substrate for the 
sol-gel coating. The coating was performed employing a dip-coater (KSV DC; KSV NIMA, 
Espoo, Finland). Discs and implants were immersed in the sol-gel solution at a speed of 
60 cm min-1, left immersed for one minute, and removed at a 100 cm min-1. Finally, the 
samples were cured for 2 h at 80 ºC. 
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2.3. Physicochemical characterisation of coated titanium discs 
The surface topography of samples was characterised using scanning electron 
microscopy (SEM) employing the Leica-Zeiss LEO equipment under vacuum (Leica, 
Wetzlar, Germany). Platinum sputtering was applied to make the materials more 
conductive for the SEM observations. An optical profilometer (interferometric and 
confocal) PLm2300 (Sensofar, Barcelona, Spain) was used to determine the roughness. 
Three discs of each type were tested. Three measurements were performed for each 
disc to obtain the arithmetic average values of roughness (Ra). An atomic force 
microscope (AFM, Bruker Multimode, Billerica, MA, USA) was employed to evaluate the 
nanocomponents of roughness. Measurements were carried out at scan size of 1 μm 
and at scan rate of 0.3 Hz (n = 3). The results were analysed using the NanoScope 
Analysis software (http://nanoscaleworld.bruker-axs.com/nanoscaleworld/media/p/775. 
aspx). The contact angle was measured using an automatic contact angle meter OCA 
20 (Dataphysics Instruments, Filderstadt, Germany). Ten µL of ultrapure water were 
deposited on the disc surfaces at a dosing rate of 27.5 μL s-1 at room temperature. 
Contact angles were determined using SCA 20 software (Dataphysics Instruments, 
Filderstadt, Germany). Six discs of each material were studied, after depositing two 
drops on each disc. 
2.4. In vitro assays 
2.4.1. Cell culture 
MC3T3-E1 (mouse calvaria osteosarcoma cell line) cells were cultured on the 
35M35G30T-coated and uncoated titanium discs at a concentration of 1 × 104 cells/well, 
in 24-well culture NUNC plates (Thermo Fisher Scientific, Waltham, MA, USA). The 
medium contained Dulbecco Modified Eagle Medium (DMEM) with phenol red (Gibco-
Life Technologies, Grand Island, NY, USA), 1% 100× penicillin/streptomycin (Biowest 
Inc., Riverside, KS, USA) and 10% fetal bovine serum (FBS) (Gibco-Life Technologies, 
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Grand Island, NY, USA). After incubation for 24 hours at 37 ºC in a humidified (95%) 
atmosphere of 5% CO2, the medium was replaced with an osteogenic medium composed 
of DMEM with phenol red 1×, 1% penicillin/streptomycin, 10% FBS, 1% ascorbic acid (5 
mg mL-1) and 0.21% β-glycerol phosphate, and incubated again under the same 
conditions. The culture medium was changed every 48 hours. In each plate, a well with 
cells at the same concentration (1 × 104 cells) was used as a control of culture conditions. 
In parallel, cells were allowed to differentiate for 7, 14 and 21 days before being 
harvested for RNA isolation. 
2.4.2. Cytotoxicity 
The biomaterial cytotoxicity was assessed following the ISO 10993-5 specifications, 
measured by spectrophotometry, after contact of the material extract with the cell line. 
The 96-Cell Titter Proliferation Assay (Promega®, Madison, WI, USA) was employed to 
measure the cell viability after 24-h incubation of the cells with the extract. One negative 
control (empty well) and a positive control with latex, known to be toxic to the cells were 
used. Seventy-percent cell viability was the limit below which a biomaterial was 
considered cytotoxic. 
2.4.3. Cell Proliferation 
For measuring cell proliferation, the commercial cell-viability assay AlamarBlue® 
(Invitrogen-Thermo Fisher Scientific, Waltham, MA, USA) was used. This kit measures 
the cell viability on the basis of a redox reaction with resazurin. The cells were cultured 
in wells with the discs (3 replicates per treatment) and examined following the 
manufacturer’s protocol after 1, 3, 5 and 7 days of culture. The percentage of reduced 
resazurin was used to evaluate cell proliferation. 
2.4.4. ALP activity 
The conversion of p-nitrophenylphosphate (p-NPP) to p-nitrophenol was used to assess 
the ALP activity. The culture medium was removed from the wells, the wells were washed 
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3 times with 1 × Dulbecco’s Phosphate Buffered Saline (DPBS), and 100 µL of lysis 
buffer (0. 2% Triton X-100, 10 mM Tris-HCl pH 7.2) was added to each. The sample 
aliquots of 0.1 mL were used to carry out the assay. One hundred µL of p-NPP (1 mg 
mL-1) in substrate buffer (50 mM glycine, 1mM MgCl2, pH 10.5) was added to 100 µL of 
the supernatant obtained from the lysate. After two hours of incubation in the dark (37 
ºC, 5% CO2), absorbance was measured using a microplate reader at a wavelength of 
405 nm. ALP activity was obtained from a standard curve obtained using different 
solutions of p-nitrophenol and 0.02 mM sodium hydroxide. Results were presented as 
mmol of p-nitrophenol/hour (mmol PNP h-1). The data were expressed as ALP activity 
normalised by the total protein content (µg µL-1) obtained using Pierce BCA assay kit 
(Thermo Fisher Scientific, Waltham, MA, USA) after 7 and 14 days. 
2.4.5. RNA isolation and cDNA synthesis 
Total RNA was prepared from the cells grown on the sol-gel coated titanium discs, using 
Qiagen RNeasy Mini kit (Qiagen, Hilden, Germany), following digestion with DNaseI 
(Qiagen), according to the manufacturer’s instructions. The quantity, integrity and quality 
of the resulting RNA were measured using NanoVue® Plus Spectrophotometer (GE 
Healthcare Life Sciences, Litlle Chafont, United Kingdom). For each sample, about 1 µg 
of total RNA was converted to cDNA using PrimeScript RT Reagent Kit (Perfect Real 
Time) (TAKARA Bio Inc., Shiga, Japan). The resulting cDNA was diluted in DNase-free 
water to a concentration suitable for reliable RT-PCR analysis. 
2.4.6. Quantitative Real-time PCR 
Prior to the RT-qPCR reaction, primers for ALP and IL6 genes were designed from 
specific DNA sequences for these genes available from NCBI 
(https://www.ncbi.nlm.nih.gov/nuccore) using PRIMER3plus software tool 
(http://www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi). Expression levels 
were measured using primers purchased from Life Technologies S.A. (Gaithersburg, 
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MD), GADPH sense TGCCCCCATGTTTGTGATG; GADPH antisense 
TGGTGGTGCAGGATGCATT; ALP sense CCAGCAGGTTTCTCTCTTGG; ALP 
antisense CTGGGAGTCTCATCCTGAGC; IL6 sense AGTTGCCTTCTTGGGACTGA 
and IL6 antisense TCCACGATTTCCCAGAGAAC. All primers are listed from 5′ to 3′ and 
GADPH was used as a housekeeping gene to normalise the data obtained from the 
RT-qPCR and calculate the relative fold-change between conditions. qPCR 
reactions were carried out using SYBR PREMIX Ex Taq (Tli RNase H Plus) (TAKARA 
Bio Inc., Shiga, Japan), in an Applied Biosystems StepOne Plus™ Real-Time PCR 
System (Foster City, California, USA). The cycling parameters were as follows: an initial 
denaturation step at 95 ºC for 30 s followed by 95 ºC for 5 s and 60 ºC for 34 s for 40 
cycles. The final melt curve stage comprised a cycle at 95 ºC for 15 s and at 60 ºC, for 
60 s. 
2.4.7. Statistical analysis 
Data were submitted to one-way analysis of variance (ANOVA) and to a Newman-Keuls 
multiple comparison post-test, when appropriate. Differences with p ≤ 0.05 were 
considered statistically significant. 
2.5. In vivo experimentation 
To assess the in vivo behaviour of the two biomaterials, the bare and coated dental 
implants were surgically placed in the tibia of New Zealand rabbits (Oryctolagus 
cuniculus). This implantation model is widely used to study the osseointegration of dental 
implants [13]. All the experiments were conducted in accordance with the protocols of 
Ethical Committee of the Valencia Polytechnic University (Spain), the European 
guidelines and legal conditions laid in R. D. 223/1988 of March 14th, and the Order of 
October 13rd, 1988, of the Spanish Government on the protection of animals used for 
experimentation and other scientific purposes. The rabbits were kept under 12-h span 
darkness-light cycle; room temperature was set at 20.5 ± 0.5 ºC, and the relative humidity 
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ranged between 45 and 65%. The animals were individually caged and fed a standard 
diet and filtered water ad libitum. Dental implants were supplied by Ilerimplant S.L. 
(Lleida, Spain). These were internal-connection dental implants, made with titanium 
grade 4 (trademark GMI), of 3.75-mm diameter and 8-mm length, Frontier model with 
SAE surface treatment. Overall, 10 implants were used, 5 uncoated (SAE-Ti) and 5 
coated with the 35M35G30T sol-gel composition. They were all implanted under the 
same conditions. 
5 rabbits were employed to carry out the assay, all of them weighing between 2000 and 
3000 g, aging near the physeal closure (indicative of an adequate bone volume). The 
implantation period for the experimental model was 2 weeks. Implants were inserted in 
both left and right proximal tibiae, each animal receiving two implants (one SAE-Ti 
sample and one sol-gel coated sample). Animals were sedated (chlorpromazine 
hydrochloride) and prepared for surgery, and then anaesthetized (ketamine 
hydrochloride). A coetaneous incision was made to the implantation site in the proximal 
tibia. The periosteum was removed, and the osteotomy was performed using a low 
revolution micromotor and drills of successive diameters of 2, 2.8 and 3.2 mm, with 
continuous irrigation. Implants were placed by press-fit, and surgical wound was sutured 
by tissue planes, washed with saline water and covered with plastic spray dressing 
(Nobecutan, Inibsa Laboratories, Barcelona, Spain). After the implantation period, 
animals were euthanised by carbon monoxide inhalation, and the implant screws were 
retrieved to study the surrounding tissues. The samples were embedded in methyl 
methacrylate, and 25–30 µm sections were obtained using EXAKT Technique (EXAKT 
Technologies, Inc., Oklahoma, USA). Slides were sequentially stained with Stevenel’s 
blue and van Gieson’s picro-fuchsin following the procedure described by Maniatopoulos 
et al. [14]. Digital images of the tissues surrounding the implant threads were recorded 
with a brightfield Leica DM4000 B microscope and a DFC420 digital camera using 1.6, 
5, 10, 20 and 100 objectives. The bone–implant contact in the cortical region of the 
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implant and the length of osteoclast-like and foreign body giant cells in contact with the 
implant surface of threads in the medullar bone cavity were evaluated using the image-
processing program ImageJ 1.48 (National Institutes of Health, USA, 
http://imagej.nih.gov/ij). 
2.6. Adsorbed protein layer 
Sol-gel-coated and uncoated titanium discs were incubated in a 24-well plate for 180 min 
in a humidified atmosphere (37 ºC, 5% CO2), after the addition of 1 mL of human blood 
serum from male AB plasma (Sigma-Aldrich, St. Louis, MO, USA). 
The serum was removed, and, to eliminate the non-adsorbed proteins, the discs were 
rinsed five times with ddH2O and once with 100 mM NaCl, 50 mM Tris-HCl, pH 7.0. The 
adsorbed protein layer was collected by washing the discs in 0.5 M triethylammonium 
bicarbonate buffer (TEAB) with 4% of sodium dodecyl sulphate and 100 mM of 
dithiothreitol (DTT). Four independent experiments were carried out for each type of 
surface; in each experiment, four discs for each material were processed. The protein 
content was quantified before the experiment (Pierce BCA assay kit; Thermo Fisher 
Scientific, Waltham, MA, USA), obtaining a value of 51 mg mL-1. 
2.7. Proteomic analysis 
Proteomic analysis was performed as described by Romero-Gavilán et al. [6], with minor 
variations. Briefly, the eluted protein was in solution digested following the FASP protocol 
established by Wisnewski et al. [15] loaded onto a nanoACQUITYUPLC system 
connected online to an SYNAPT G2-Si MS System (Waters, Milford, MA, USA). Each 
material was analysed in quadruplicate. Differential protein analysis was carried out 
using Progenesis software (Nonlinear Dynamics, Newcastle, UK) as described before 
[6], and the functional annotation of the proteins was performed using PANTHER 
(www.pantherdb.org/) and DAVID Go annotation programmes 
(https://david.ncifcrf.gov/).  
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3. Results 
3.1. Synthesis and physicochemical characterisation 
The sol-gel synthesis was carried out, and a well-adhering and homogenous coating was 
obtained on SAE-Ti discs. SEM micrographs showed substantial morphological 
differences between the bare and coated titanium discs (Figure 1a – 1d). The sol-gel 
material partly covered the initial roughness (shown by the data obtained using optical 
profilometer). After the 35M35G30T sol-gel treatment, Ra decreased to 0.79 ± 0.09 µm 
from its original value of 1.15 ± 0.10 µm for SAE-Ti surfaces. AFM images display the 
morphological properties of both surfaces on a lower scale (Figure 1e and 1f). The 
uncoated surface showed a Ra value of 19.00 ± 2.05 nm, while the sol-gel coating 
involved a reduction of the roughness nanocomponents displaying a Ra value of 1.75 ± 
0.94 nm. The contact angle measurements revealed a significant increase in wettability 
as a consequence of coating. Uncoated and coated discs presented angles of 79.55 ± 
7.51º and 50.39 ± 3.78º, respectively. Thus, the sol-gel-coated material was more 
hydrophilic than the initial SAE-Ti, possibly due to its hydroxyl group content [8]. 
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Figure 1. SEM micrographs of SAE-Ti (A and C) and hybrid sol-gel coating (B and D). 
Scale bars: A and B, 10 µm and C and D, 1 µm. 
 
3.2. In vitro assays 
3.2.1. Cell cytotoxicity, proliferation and ALP activity 
Neither of the examined materials was cytotoxic (data not shown). The proliferation and 
ALP activity assays do not show significant differences between the two materials at 
most of the time points, except for the proliferation assay at 3 days period, in which the 
35M35G30T boosts higher values of proliferation (Figure 2). 
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Figure 2. MC3T3-E1 in vitro assays: a) MC3T3-E1 cell proliferation after 1, 3, 5 and 7 days of cell 
culture with SAE-Ti (white bar) and 35M35G30T (grey bar). b) ALP activity (mM PNP h-1), 
normalised to the amount of total protein (µg µL-1), in the MC3T3-E1 cells cultivated on SAE-Ti 
(white bar) and 35M35G30T formulation (grey bar). Cells in an empty well were used as a positive 
control (black bar). Statistical analysis was performed using one-way ANOVA with a Kruskal-
Wallis post- test (*, p ≤ 0.05). 
 
3.2.2. mRNA expression levels 
After 14 days of incubation, there were found large and statistically significant differences 
(p < 0.001) between mRNA expression levels for ALP and IL-6 in the cells cultivated on 
35M35G30T discs and those grown on SAE-Ti and the blank controls (Figure 3), showing 
the bioactive potential of this coating formulation. 
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Figure 3. Gene expression of osteogenic markers (a) ALP and (b) IL6 on MC3T3-E1 
osteoblastic cells cultured on SAE-Ti (white bar) and 35M35G30T (grey bar). Cells in an 
empty well were used as a positive control (black bar). The relative mRNA expression 
was determined by RT-PCR after 7 and 14 days of cell culture. Statistical analysis was 
performed using one-way ANOVA with a Kruskal-Wallis post-test (***, p ≤ 0.001). 
 
3.3. In vivo experimentation 
No statistically significant differences were found between osseointegration levels for the 
uncoated (SAE-Ti) and sol-gel-coated implants during the studied period (Figure 4, A-
B). On the coated implants, transparent layers of undegraded material (Figure 4, B and 
D) were observed in the deep areas of the screw grooves. This coating layer was thinner 
or absent in the threads in contact with or next to the bone tissue. It was more evident in 
the grooves of the implant located in the medullary cavity of the bone and away from the 
trabeculae of bone tissue. Along this medullary zone, in the implant–tissue interface 
(SAE-Ti samples) or coating–tissue interface (35M35G30T samples), were observed 
connective tissue, inflammatory components and two types of multinucleated cells. One 
of these cell types had the size and morphological characteristics similar to osteoclasts, 
and the other was composed of larger cells, similar to foreign body giant cells (Figure 4, 
C-D and insets). The length of that interface and the length of the osteoclast-like and 
giant cells were measured. The cells shorter than 100 µm were considered osteoclast-
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like cells and the larger cells were classified as giant cells. Osteoclastic cells from the 
uncoated and coated implants were of similar length (44.4 ± 21.6 µm, N = 272 and 40.4 
± 27.9 µm, N = 50, respectively). The giant cells were smaller in the SAE-Ti than in 
35M35G30T samples (cell length 162.0 ± 73.6 µm, N = 66 and 268.0 ± 140.0 µm, N = 
46, respectively). The difference was statistically significant (p < 0.001, non-parametric 
Mann–Whitney test). In the coated implants, the areas of bone regeneration showed 
fewer giant cells, and fibrous capsules between the bone tissue and implant were not 
observed. 
 
 
 
 
 
 
 
 
 
Figure 4. Microphotographs of SAE-Ti and 35M35G30T samples. Panoramic images of 
SAE-Ti (A) and 35M35G30T (B) samples show the implant regions close to the cortical 
bone and in the medullary cavity. The regions enclosed in white-edged squares in A and 
B are shown in panels C and D, respectively. In the panel C, several rounded and 
elongated osteoclast-like and giant cells touch the surface of the implant. In the D panel, 
two giant cells, flanking a region with inflammatory cells, are in contact with the 
transparent coating of the implant surface. Lower regions of the C and D images are 
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shown magnified in the corresponding insets. Stevenel’s blue and van Gieson’s picro-
fuchsin staining was used. Scale bars: A and B, 1 mm; C and D, 0.1 mm; insets, 0.02 
 
3.4. Proteomic analysis 
LC-MS/MS analysis detected and identified 133 proteins for each material. Progenesis 
QI software was employed to study differences between protein adsorption on the SAE-
Ti and hybrid silica-treated surfaces. DAVID and PANTHER tools were used to classify 
these proteins according to their function. 
The comparison of the characteristic proteins attached to the two biomaterials showed 
that 16 proteins were more abundant on the SAE-Ti than on the coated surfaces (Table 
1).  
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The list in Table 1 shows some proteins related to blood coagulation processes, such as 
FA11, THRB and PROC. Notably, a large number of apolipoproteins adsorbed 
preferentially to the titanium surface in comparison with the sol-gel material (APOA, 
APOA1, APOA4, APOA5, APOC1, APOC2, APOC4 and APOE), as well as SAA4, 
classified as high-density lipoprotein by DAVID. PF4V, KCRM, VTNC and SEPP1 were 
also identified as more abundant in SAE-Ti elutions. 
PANTHER chart in Figure 5a displays the classification of biological processes in which 
the proteins characteristic for titanium surfaces are involved. Among the identified 
processes, the most significant were the cellular (14%) and metabolic (16%) processes 
and the response to stimulus (16%). Molecules with functions related to the immune 
system were also detected although they constituted only 2% of the proteins. 
 
Table 1. Progenesis analysis of proteins differentially attached to SAE-Ti. 
Description Accession 
Confidence 
score 
Average 
SAE-Ti 
Average 
35M35G30T 
ANOVA 
(p) 
Ratio 
SAE-Ti/ 
35M35G30T 
Platelet factor 4 variant PF4V_HUMAN 106.83 2.05E+05 3.95E+03 6.62E-04 52.00 
Coagulation factor XI FA11_HUMAN 337.82 2.21E+05 9.18E+03 4.67E-02 24.06 
Apolipoprotein C-IV APOC4_HUMAN 80.60 1.18E+05 5.39E+03 3.91E-05 21.81 
Vitamin K-dependent 
protein C 
PROC_HUMAN 124.64 2.08E+05 1.36E+04 4.21E-03 15.27 
Serum amyloid A-4 
protein 
SAA4_HUMAN 150.29 2.24E+06 2.11E+05 1.09E-04 10.60 
Creatine kinase M-type KCRM_HUMAN 104.21 1.58E+04 1.74E+03 1.66E-03 9.06 
Prothrombin THRB_HUMAN 375.17 1.91E+06 2.72E+05 1.15E-03 7.02 
Apolipoprotein E APOE_HUMAN 1836.86 2.54E+07 4.62E+06 9.73E-03 5.51 
Vitronectin VTNC_HUMAN 430.96 1.03E+07 2.06E+06 3.53E-04 4.98 
Apolipoprotein C-I APOC1_HUMAN 163.40 3.22E+06 6.53E+05 9.19E-03 4.94 
Apolipoprotein A-V APOA5_HUMAN 134.27 4.82E+04 1.03E+04 2.61E-04 4.67 
Selenoprotein P SEPP1_HUMAN 242.92 1.99E+05 6.33E+04 4.35E-03 3.14 
Apolipoprotein(a) APOA_HUMAN 108.16 8.15E+04 3.90E+04 3.74E-02 2.09 
Apolipoprotein A-IV APOA4_HUMAN 1044.44 1.36E+06 7.07E+05 2.24E-02 1.92 
Apolipoprotein A-I APOA1_HUMAN 1051.15 1.25E+07 6.68E+06 1.19E-03 1.87 
Apolipoprotein C-II APOC2_HUMAN 133.73 3.20E+05 1.85E+05 4.09E-02 1.73 
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Figure 5. PANTHER pie chart of the biological processes associated with the proteins 
differentially adhering to SAE-Ti (a) and 35M35G30T (b). 
Table 2 shows the 20 proteins more predominant on the 35M35G30T biomaterial than 
on untreated surfaces. A large proportion of these proteins is related to the immune 
response and the complement system, such as C1R, CO5, CO6, CO7, CO8A and CO8B 
proteins and the immunoglobulins IGJ, IGHA1 and IGHM. The proteins AFAM, HPT, 
A1AT and A2MG were also detected. 
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For the 35M35G30T samples, PANTHER analysis identified, among others, protein 
functions associated with cellular (19%) and metabolic (10%) processes, in similarity to 
the titanium-only results. However, in this case, the proportion of proteins related to 
immune system processes reached 17% (Figure 5b). 
 
 
4. Discussion 
There is an ever-increasing interest and research on the biomaterial science industry for 
the development of implants with bioactive properties in the scope of decreasing the 
recovery times following the post-implantation procedure. Chemical and physical surface 
modifications of the implants are state-of-the-art areas in which researchers focus their 
attention, due to the fact that these modifications can ultimately influence cell behavior 
[16]. To a large extent, this behaviour is affected by the proteins attached to the surface 
of the implant, representing a microenvironment whose characteristics determine the 
success of the implantation [17]. It is widely known that the titanium is not, by itself, 
bioactive; even though it has osteoconductive properties, it is not osteoinductive [2]. To 
confer osteoinductive characteristics to the titanium devices, imply the modification of 
the physicochemical properties of their surfaces. This alters the conformation, quantity 
and type of proteins that attach to the implant in contact with biological fluids [18]. 
This experimental study was designed to compare and characterise two distinct 
surfaces, one an uncoated sandblasted acid-etched titanium (SAE-Ti), and the other 
coated with a silica sol-gel hybrid 35M35G30T biomaterial, regarding their 
physicochemical properties, in vitro and in vivo behaviour and the characterization of the 
protein layer adsorption onto each surface.  
Apart from the obvious chemical differences between the titanium surfaces and silicon 
coatings, their morphological characterisation revealed specific properties of these 
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surfaces, showing that the application of the sol-gel coating decreases surface 
roughness at micro and nano-level and increases hydrophilicity. These distinct 
characteristics might ultimately affect both the protein adsorption and the biological 
behaviour of the biomaterial. Indeed, in vitro results demonstrated an increase in the 
bioactive potential of the sol-gel-coated implant in comparison with the uncoated 
titanium. In particular, it was observed changes in the mRNA expression levels, as it was 
found an almost 4-fold increase in the expression of the ALP mRNA and at least 2-fold 
increase in the expression of the mRNA for IL6 (Figure 3). ALP is expressed early in the 
development of the bone and during cartilage calcification [19] and is a well-known 
biomarker for osteoblastic differentiation. This marker has been used for the assessment 
of fracture healing [20]. IL-6 is a regulator of the differentiation of pre-osteoblastic cells 
and initiates apoptosis in the mature osteoblasts. Moreover, the expression of its 
receptor is high during differentiation of osteoblasts in vitro [21]. It has also been reported 
as a direct stimulator of RANKL and OPG mRNA expression in the mouse bone tissue 
[22], promoting prostaglandin production and, thus, modulating the inflammatory 
potential [23]. Interestingly, IL-6 can act as an ALP induction factor during the 
inflammatory phase of wound repair in the skin [24] and even in bone tissue remodelling 
[25]. Therefore, the 35M35G30T material might have a role in promoting osteoblastic 
activity. 
In vivo results for the two examined surfaces did not show clear differences in bone repair 
during the tested period even though the in vitro experiments demonstrated higher 
bioactivity in the coated samples. Nevertheless, there was a significant increase in the 
immune complex activation on the sol-gel-coated implants. This was demonstrated by 
the higher abundance of the foreign body giant cells (FBGC) surrounding the residual 
areas of non-degraded material, in comparison with the SAE-Ti (Figure 4). The presence 
of FBGCs in degradable materials is quite common as their activity is needed for the 
recovery of the implanted tissue. Without it, immune structures like thick fibrous capsules 
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might be formed around the material, with all the associated disadvantages [26]. In fact, 
for the coated surfaces, in the areas of bone regeneration, it occurs a clear decrease in 
the number of giant cells and no presence of fibrotic tissue. 
The comparison between the composition of protein layers on SAE-Ti and 35M35G30T 
coating revealed many proteins differentially attached to these surfaces. This distinct 
affinity of some proteins to these materials could be attributed to their different 
physicochemical properties such surface chemistry, wettability or roughness [27,28]. In 
this sense, for example, an increase in surface roughness could be involved with 
changes in the adsorption of specific proteins [29].  
Interestingly, among the protein group characteristic for titanium, the PF4V protein was 
the most abundant (52-fold increase in comparison with the sol-gel treated samples). 
This protein is a platelet chemokine inhibiting both angiogenesis and tumour growth [30]. 
However, its specific role in bone regeneration processes remains unclear. Remarkably, 
a large number of apolipoproteins were attached predominantly to the SAE-Ti surface. 
Cho et al. have reported that apolipoproteins might prevent the activation of innate 
immunity response, and have an anti-inflammatory potential [31]. These results indicate 
that the high biocompatibility of titanium might be related to the preferential adsorption 
of this family of proteins onto its surface. Other studies suggest that the 
immunomodulatory role of apolipoproteins might be associated with the polarisation of 
macrophages in their anti-inflammatory phenotype [32,33]. Similarly, VTNC has been 
identified as an inhibitor of the complement cascade activation [34]. This protein has an 
important role in the interleukin IL-4 adhesion to biomaterials, leading the macrophage 
polarisation to their M2 reparative phenotype [16]. VTNC also interacts with the 
coagulation cascades, contributing to thrombus formation, and participates in the 
establishment of vascular homoeostasis, wound repair and tissue regeneration [35]. This 
protein promotes the osteogenesis by boosting the osteoblast differentiation [36]. APOE 
protein was also found predominantly on the SAE-Ti surfaces. This protein is involved in 
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the regulation of bone metabolism; its role in the bone tissue is probably related to its 
effect on vitamin K uptake into osteoblasts [37]. Proteins FA11, THRB and PROC play 
an important role in blood clotting. FA11 and THBR participate in the activation of the 
blood coagulation pathway. PROC is involved in the regulation of this pathway, through 
the inactivation of Va and VIIIa factors in the presence of phospholipids [38,39]. 
At the same time, proteomic analysis to the proteins more predominantly found in the 
silica sol-gel material (in comparison with the SAE-Ti) revealed a prevalence of proteins 
belonging to the complement system, namely CO5, CO8B, CO8A, CO7, C1R and CO6 
[40], as well as the immunoglobulins IGJ, IGHM and IGHA1. This result was supported 
by the PANTHER analysis, which found a pronounced increase in the attachment of 
proteins related to immune system, from 2% on the uncoated SAE-Ti to 17% on the sol-
gel coating (Figure 5). Interestingly, there was not found C-reactive protein adsorption, 
which, in a previous study, has been reported as related to acute/chronic inflammation 
processes and put forward as a bad biocompatibility biomarker [41]. 
This data unveils the relationship that an increment in immune response can suppose 
an increase on the activity of osteogenic markers (ALP and IL6) observed in the in vitro 
assays. This augmented immune system activation was also seen in vivo (Figure 4). 
The implantation of biomedical devices entails a natural and significant immune 
response to the foreign material. The migration of white blood cells to the implantation 
site is caused by complement cascade proteins adsorbed on the surface of the implant. 
The consequent immune response is guided by cytokines that are activated and released 
by white blood cells, e.g., macrophages [42]. These cytokines can be responsible for 
producing a natural inflammatory reaction, giving the kick-start to the healing processes 
in the damaged tissue. An interaction between the host and the implant surface will result 
in the release of such molecules and trigger the activation of a series of cascades, 
determining the outcome of the implantation. The results obtained here show that an 
increase in the immune response to the implanted material might affect its bioactive 
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potential, as a result of the interactions between the immune and skeletal systems [43]. 
Such interactions, as long as the release of the immune product is controlled, might help 
to modulate the bioactivity of material towards the bone cells [44]. 
 
5. Conclusion 
In summary, this study shows the importance of the adsorbed layer of proteins in the 
bioactivation of the material. The proteins from these layers, whose composition depends 
on the intrinsic characteristics of the material, might trigger the bioactivation process. 
Indeed, it has been found a significant deposition of complement-related proteins. These 
proteins intervene in processes such as the maintenance of cellular turnover, healing, 
proliferation and regeneration, apart from their role in the immune processes. This 
assumes a prolonged presence of the FBCGs on the regenerating tissue, and at the 
same time, a boost in the osteogenic potential, even though no effect on the in vivo 
regenerative potential is found. 
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